The regulatory file for acetyl-L-carnitine
Acetyl-L-carnitine is sold as a food supplement ingredient and as a dietary ingredient, and the regulatory file is built around the exact form, the destination and the finished-product dose. The catalog material is the hydrochloride, CAS 5080-50-2, and the parent L-carnitine is a different ingredient with a different file. Permission, maximum level, label and claim are four separate questions.
Acetyl-L-carnitine and L-carnitine are separate ingredients on the label and in the file; the form, the market route and the daily dose have to agree.
The instruments behind the file
One certificate can be enough in one market and incomplete in another. The table is a map, not a legal opinion; the text of each instrument and the national rule decide a specific product.
| Market | Main instruments | What they settle |
|---|---|---|
| European Union | Directive 2002/46/EC; Regulations 1169/2011, 1924/2006, 2015/2283 and 2023/915 | Supplement status, labelling, claims, novel-food history and contaminants |
| United States | FD&C Act as amended by DSHEA; 21 CFR 111 and 101.36 | Dietary ingredient status, cGMP and the Supplement Facts panel |
| United Kingdom | Food Supplements Regulations 2003 and retained food law | Permission and labelling in Great Britain; Northern Ireland follows the EU regime |
Great Britain applies retained law as of this review, but it is maintained by UK law and can change on a different timetable. Northern Ireland follows EU rules, so an EU-compliant file is the starting point there and a GB-only file is not.
The European Union
Acetyl-L-carnitine is not a vitamin or a mineral, so Directive 2002/46/EC does not harmonise it as a nutrient. It sits among the substances the Directive leaves to national rules; a member state may set a maximum level, require a notification or restrict a form. There is no single EU maximum for the ingredient, and a label built on another country's level is not automatically valid.
The first documentary check is the novel-food status under Regulation (EU) 2015/2283. As of this review, the EU Novel Food Catalogue records acetyl-L-carnitine as not novel in food, with a catalogue entry rather than an authorisation; keep the catalogue printout, its date and the form it covers in the file. A catalogue entry is an information tool, not a legal authorisation, and the buyer's team confirms the status for the exact form and use.
Labelling follows Regulation 1169/2011 and the national supplement rules: the ingredient name, the quantity per portion and the form. Acetyl-L-carnitine has no Nutrient Reference Value, so a percentage of an NRV cannot be shown for it.
The United States
Acetyl-L-carnitine is marketed as a dietary ingredient. The supplement route runs under DSHEA and the cGMP rules in 21 CFR 111, with a Supplement Facts panel under 21 CFR 101.36. A structure or function statement is allowed with the DSHEA disclaimer in 21 CFR 101.93; a disease claim is not.
A conventional food is a different route. The supplement file does not authorise a beverage, and the intended use has to match the filing the buyer relies on. The supplier names the basis it relies on and the document behind it; the buyer checks the finished product and the claim.
Contaminants and limits
The contaminant panel is a finished-product calculation, not only a drum result. The table below is the usual starting point for a food-supplement file; the current destination text and the daily dose decide the final limit.
| Parameter | Typical supplement reference | What the file should show |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | Lot result, method and the finished-product calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | Lot result and any category exception that applies |
| Mercury (Hg) | 0.10 mg/kg in the supplement | Lot result and method |
| Arsenic (As) | Customer or market limit | The agreed limit and the method |
| Microbiology | Process hygiene and the buyer's specification | Counts and absence statements for the lot |
EU Regulation 2023/915 sets, as of this review, the lead, cadmium and mercury maxima for food supplements; arsenic has no harmonised EU maximum, so the catalog line is contractual. The catalog sits at the legal line for lead, cadmium and mercury, which leaves no margin for analytical uncertainty or for a higher-dose serving. A lot that passes the powder limit can still fail the finished-product calculation.
Claims and the label
In the EU a health claim needs authorisation under Regulation 1924/2006 and a place on the register. As of this review the register carries no authorised claim for acetyl-L-carnitine; EFSA's 2011 opinion on the cognitive-function claim did not establish a cause-and-effect relationship. A claim written for L-carnitine is a different ingredient and does not transfer.
In the US the structure or function route is open with substantiation and the disclaimer, and it does not extend to a disease. The acetyl group is chemistry, not a claim; a sentence about acetyl donation or mitochondrial transport is mechanism language, and it still needs review. This site makes no health claim for the ingredient.
What the file must contain
- A lot certificate with assay and basis, rotation conditions, chloride, loss on drying, metals and microbiology, matching the lot code on the pack.
- The versioned specification it was released against, naming the hydrochloride and the mesh.
- A safety data sheet, allergen and GMO statements, and a food-contact declaration for the pouch or liner.
- A manufacturing site and country-of-origin statement naming the actual producer.
- An EU novel-food statement with the catalogue reference and date, and a US dietary ingredient statement.
- A residual-solvent statement and a stability summary for the pack, with the assigned retest period.
The certificate supports the material, not the claim. A claim revision never reopens the specification, and a change of form, source or site should trigger a new specification and a new market review.
Checklist before the first order
- The form is named on the specification, the certificate and the label, and all three agree.
- The destination's national level rule has been checked, not assumed from the EU position.
- The contaminant results are converted to the finished-product dose.
- The label and the claim have been reviewed for the destination.
- The novel-food and dietary-ingredient statements cover the exact form.
- The lot code runs through the certificate, the pack and the retained sample.
The market instruments are summarised on the EU regulatory page, the US page and the UK page. The release tests are on the COA page, the tests that separate the forms are on the identity page, and the parent ingredient is on the L-carnitine page. The product page carries the catalog specification, the analytical methods are collected under methods, and the release workflow is on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation